Article

Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease

The Lancet Neurology
DOI: 10.1016/S1474-4422(19)30329-1
3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Paulsen, J. S., & Coffey, C. S. (2019, October 1). Antisense oligonucleotides might change the therapeutic landscape for Huntington’s disease. The Lancet Neurology. Lancet Publishing Group. https://doi.org/10.1016/S1474-4422(19)30329-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free